Chandirasegaran Massilamany

Chandirasegaran Massilamany is a seasoned immunologist with extensive experience in immuno-oncology and the development of CAR T cell technologies at CRISPR Therapeutics since May 2018, currently serving as Associate Director and previously as Senior Scientist. Prior to this, Chandirasegaran held a position as Scientist II at the National Cancer Institute, focusing on PD-1 signaling mechanisms in chronic viral infections. Additionally, a research assistant professor role at the University of Nebraska-Lincoln allowed for significant contributions to autoimmune myocarditis and vaccine development for viral infections. Academic qualifications include a PhD in Immunology from the University of Nebraska-Lincoln, an MVSc in Virology/Immunology from the Indian Veterinary Research Institute, and a DVM in Veterinary and Animal Sciences from Rajiv Gandhi College. Early career experience included veterinary practice and research in virology during early educational endeavors.